This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets.
New marketing authorisations
Table 1 shows the new marketing authorisations for March 2025
|
New Marketing Authorisations
|
|
Product name and target species
|
Active substance
|
Authorisation Holder, territory, and distribution category
|
Therapeutic group
|
|
Food Animals
|
|
Censutrim 200 mg/ml + 40 mg/ml Solution for Injection for Cattle, Pigs, Horses, Dogs and Cats
|
Sulfadiazine, Trimethoprim
|
DUGV (UK) Limited
NI, POM-V
|
Antimicrobial
|
|
Non-food Animals
|
|
ButorVet 10 mg/ml Solution for Injection for Horses, Dogs and Cats
|
Butorphanol
|
C&H Generics Ltd
GB & NI, POM-V
|
Neurological Agent analgesic
|
See the VMD’s Product Information Database (www.gov.uk/check-animal-medicine-licensed) for more information on each of these products. There may be a delay before formal documentation is available for some Northern Ireland products, from the European Medicines Agency.
The timing of the product being placed on the market is an issue for the marketing authorisation holder.
For more information, contact the VMD at postmaster@vmd.gov.uk